|
Volume 271,
Number 16,
Issue of April 19, 1996 pp. 9730-9738
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Human
T-cell Leukemia Virus Type I Tax Masks c-Myc Function through a
cAMP-dependent Pathway (*)
(Received for publication, December 11, 1995; and in revised form, January 30, 1996)
Oliver J.
Semmes
,
John
F.
Barrett
(1),
Chi V.
Dang
(1),
Kuan-Teh
Jeang (§)
From the Molecular Virology Section, Laboratory of Molecular
Microbiology, NIAID, National Institutes of Health, Bethesda, Maryland
20892 Division of Hematology, Department of Medicine, Johns
Hopkins University School of Medicine, Baltimore, Maryland 21205
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Human T-cell leukemia virus type I Tax is a pleiotropic gene
regulator that functions through CREB/ATF- and NF- B-mediated
pathways. In most contexts, Tax is a potent gene activator. Here, we
describe an unexpected finding of Myc repression by Tax. In cells that
overexpress human T-cell leukemia virus type I Tax, the detection of
c-Myc protein in the nucleus by a monoclonal antibody was masked. Tax
prevented immunological visualization of a Myc epitope contained within
amino acids 45-104, resulting in interference with Myc function
in transcription and in anchorage-independent cell growth. Tax did not
affect steady-state protein levels since detection of c-Myc with other
antibodies was unperturbed. Four observations suggest that this Tax-Myc
interaction is mediated through CREB/ATF signal transduction. 1) Tax
point mutants, selectively defective for activation of CREB/ATF but not
NF- B, failed to mask c-Myc; 2) masking of Myc was abolished when
Tax-expressing cells were treated with protein kinase inhibitor H-9; 3)
Tax-specific shielding of Myc is absent in cells (B1R) that are
genetically defective for cAMP signaling; and 4) forskolin treatment of
cells mimicked Tax in masking the Myc epitope. Considered collectively,
these findings suggest a regulation of Myc function at the level of
localized protein conformation.
INTRODUCTION
Human T-cell leukemia virus type I (HTLV-I) ( )is the
etiologic agent for adult T-cell leukemia
(ATL)(1, 2, 3) . HTLV-I encodes a 40-kDa
phosphoprotein, Tax, which is essential for viral
transcription(4, 5, 6, 7) . Tax has
been proposed to be involved in molecular events leading to ATL
(reviewed in (8, 9, 10, 11) ).
Numerous cellular findings, including the demonstration that Tax
expression leads to immortalization of T-lymphocytes(12, 13) and transformation of rat fibroblasts (14, 15) ex vivo, are consistent with this
proposition. In animals, transgenic mice that express Tax have
constitutively activated T-cells(16) , and targeted expression
of Tax to T-lymphocytes results in development of large granular
lymphocytic leukemias(17) . How Tax effects these cellular
changes is not well understood. It is, however, well demonstrated that
this viral activator modulates a variety of cellular processes through
signals transduced separately by CREB/ATF and NF- B (reviewed in (18) ). Transcription directed from the HTLV-I long terminal
repeat and many cellular promoters (e.g. interleukin-2,
interleukin-2R , transforming growth factor- 1, c-Fos, c-Jun,
granulocyte-macrophage colony-stimulating factor, and epidermal growth
factor receptor-1 among others(19, 20, 21) )
is potently up-regulated by Tax. Three imperfectly repeated 21-base
pair motifs, each containing a core 8-base pair cAMP-responsive
element(22, 23) , have been characterized as the cis-responsive long terminal repeat target for Tax
regulation(24, 25, 26, 27, 28) .
Tax activates the viral long terminal repeat (and cellular promoters)
by interacting with CREB/ATF (29, 30) bound at
promoter-proximal cAMP-responsive
elements(31, 32, 33, 34, 35, 36, 37, 38, 39, 40) .
Tax also activates other promoters through alternative means that are
less understood (41, 42, 43, 44) .
Additionally, another function of Tax is reflected in its ability to
induce the translocation of NF- B from the cytoplasm into the
nucleus(45, 46, 47, 48, 49) ,
thereby modulating expression of a further class of genes including
that encoding for
interleukin-2R (50, 51, 52, 53, 54) . Recent evidence indicates that signaling pathways, previously
thought to be discrete, are often
intertwined(55, 56, 57) . Homeostatically, it
makes sense that each activating event in cells should be countered by
a moderating reaction(s), although in the literature, descriptions of
the former far exceed those of the latter. Thus, depending on context,
activators should also frequently serve as repressors (reviewed in (58) ). In HTLV-I, many aspects of disease pathogenesis suggest
the existence of tight checks on viral activation function. Most
notable is the fact that <5% of all infected individuals ultimately
develop ATL and usually not before a latency period greater than
20-30 years(59, 60) . Hence, in vivo,
disease development is slow and protracted. This contrasts sharply with
the observed rapid and dramatic effects exerted by ectopic expression
of HTLV-I proteins on cultured cells (discussed in (61) ). Such
juxtaposition of findings suggests the existence of yet characterized
biological controls on viral activation. c-Myc is a 64-kDa nuclear
phosphoprotein that regulates cell proliferation and differentiation
(reviewed in (62) ). When dimerized with its heterologous
partner Max, Myc is a sequence-specific DNA-binding protein (63, 64, 65) that has pleiotropic
transcriptional activity(65, 66) . Deregulated
expression of c-Myc is linked to the the development of many human
cancers (reviewed in (62) ) and, in some context, leads to
apoptosis(67, 68) . Understandably, tight control of
Myc expression, which has been described at transcriptional and
post-transcriptional levels (reviewed in (62) ), is essential
to normal cellular metabolism. In searching for cellular targets of
HTLV-I Tax, we unexpectedly observed a novel interaction with Myc. When
cells were transfected to express Tax, the nuclear detection by a
monoclonal antibody directed to an N-terminal epitope of Myc was
masked. This effect did not affect steady-state stability/amount of Myc
since detection of protein using other antibodies was unchanged. While
Tax has been shown previously to cooperate with oncogenes (e.g.
ras) (69) in transformation, its ability to antagonize
also a second oncoprotein through presumptive regulation at the level
of local protein conformation is intriguing. We discuss the possible
biological implications of this finding.
MATERIALS AND METHODS
Plasmid ConstructsTax-expressing constructs
have been described previously(19, 70) . Wild-type Myc
and Myc deletion constructs are described elsewhere(71) .
Myc 48-175 was constructed by digestion of wild-type Myc cDNA
with SstI and religation to form the described in-frame
deletion. This fragment was transferred to a glutathione S-transferase fusion vector for subsequent expression.
Myc45-130 was constructed by polymerase chain reaction
amplification of the appropriate fragment and subsequent placement into
the same glutathione S-transferase fusion vector.
Cell Culture and TransfectionHeLa and Rat1a cells
and Rat1a derivatives were grown in Dulbecco's modified
Eagle's medium containing 2 mML-glutamine, 10%
fetal calf serum, and 100 units/ml penicillin/streptomycin. The S49.1
derivative (B1R) was grown in RPMI 1640 medium containing 2 mML-glutamine, 10% horse serum, and 100 units/ml
penicillin/streptomycin. Jurkat cells were propagated in RPMI 1640
medium containing 2 mML-glutamine, 10% fetal calf
serum, and 100 units/ml penicillin/streptomycin. For
immunofluorescence, HeLa cells were seeded at 1 10 cells onto coverslips in 100-mm culture dishes.
Calcium phosphate-mediated transfections were performed 24 h later as
described previously(72) . Cells were washed twice and then fed
with 5 ml of medium 16 h after introduction of calcium phosphate
precipitates. Cells were fixed 24 h later for microscopy. Transfection of suspension cells was achieved using Lipofectin (Life
Technologies, Inc.) according to manufacturer's suggestions.
Following transfection, the cells were attached to polylysine-coated
glass coverslips and processed for microscopy as described for adherent
cells.
Chloramphenicol Acetyltransferase AssaysHeLa
cells were seeded at 5 10 cells/well onto 6-well
tissue culture plates. Calcium phosphate-mediated transfections were
performed as described above. Extracts were made by freeze-thawing and
were assayed for chloramphenicol acetyltransferase
activity(73) . Enzymatic activity was quantitated on a Fujii
phosphoimager after resolution of acetylated forms by thin-layer
chromatography. All assays were performed within the linear range of
enzymatic activity.
Immunoblot AnalysisWhole cell extracts were made
by dissolving cell pellets in 2 Laemmli buffer (74) and
boiling for 10 min. Extracts were clarified by centrifugation and then
resolved on a 10% SDS-polyacrylamide gel. Following separation, the
proteins were transferred to polyvinylidene difluoride membrane.
Nonspecific sites were blocked by preincubation in BLOTTO(75) .
Primary antibody was reacted with the filters overnight at 4 °C in
BLOTTO. The filters were then washed in 1% casein in PBS and incubated
with an alkaline phosphatase-conjugated second antibody for 1 h at room
temperature. Excess antibody was removed with extensive washes in 1%
casein in PBS and visualized by chemiluminescence according to the
manufacturer's protocols (WesternLite, Tropix Inc.).
Confocal MicroscopyCells were seeded onto
coverslips and transfected as described above. The adherent cells were
fixed with fresh 4% paraformaldehyde (pH 7.0) for 10 min at room
temperature. Fixed cells were permeabilized with a 2-min wash in 100%
MeOH at room temperature followed by a wash in 4% bovine serum albumin
dissolved in PBS. All subsequent steps were performed in bovine serum
albumin/PBS. Appropriately diluted primary antibody was incubated with
coverslips overnight at 4 °C. Excess antibody was removed with four
washes in bovine serum albumin/PBS. Species-specific second antibody
conjugated to fluorescein isothiocyanate or tetramethylrhodamine B
isothiocyanate was then reacted with the coverslips for 1 h at room
temperature with four subsequent washes in bovine serum albumin/PBS.
The final samples were mounted onto slides and visualized using a Ziess
Axiophot confocal microscope.
RESULTS
Tax Masks Detection of a c-Myc EpitopeThe
modulatory effects of Tax on various cellular genes have been
extrapolated largely from chimeric reporter experiments and from
cell-free biochemical assays. Direct characterization of Tax effects
within intact cells has generally been difficult. To address this, we
sought to visualize in situ interactions between Tax and
endogenous transcription factors using confocal microscopy. We
transfected cells with a Tax-expressing vector. Subsequently, the
transfected cells were double-stained with anti-Tax rabbit serum (19) and a collection of mouse monoclonal antibodies specific
for selected cellular factors. Some of these factors colocalized with
Tax( ); and from one series of study, an unexpected
interaction between Tax and c-Myc was observed.When Tax-expressing
HeLa cells (Fig. 1A, arrow 1) were visualized
using anti-Myc monoclonal antibody C-8, no Myc fluorescence was
detected in the nucleus (Fig. 1B, arrow 1). In
the same field, HeLa cells that did not express Tax stained brightly
for c-Myc (Fig. 1B, arrow 2). This finding was
reproduced in all other fields, and quantitation of fluorescent signals
showed that Tax-expressing cells (Fig. 1C, trace
1) measured less than one-tenth the staining intensity of that
seen in Tax-nonexpressing counterparts (Fig. 1C, trace 2).
Figure 1:
Masking
of c-Myc by HTLV-I Tax. Tax-expressing cells were identified using
anti-Tax rabbit polyclonal antibody and Texas Red-conjugated goat
anti-rabbit (IgG) secondary antibody (A, D, and F). Myc was stained using three monoclonal antibodies, two
(C-8 and C-33) for separate epitopes in Myc (B and E)
and another (9E10) for Myc peptide, amino acids 408-439 (G). Identical fields are shown for Tax (left) and
for Myc (right). Arrows point to cells expressing
Tax, which was detected in 20% of transfected cells. Relative
expression of Myc in Tax-expressing cells (labeled as arrow 1) versus Tax-nonexpressing cells (labeled as arrow 2)
was quantitated based on fluorescent intensities and is plotted in C. In Tax-expressing cells, Myc-specific fluorescence was
absent with the C-8 monoclonal antibody (A-C). Myc was
seen when the cells were stained with the C-33 (D and E) and 9E10 (F and G) monoclonal
antibodies.
The epitope in c-Myc recognized by the C-8
monoclonal antibody was unknown. To check whether the disappearance of
Myc fluorescence was due to a reduction in steady-state protein or was
a result of epitope masking, two other Myc-specific antibodies were
tested. Anti-Myc C-33 is a monoclonal antibody directed to an epitope
different from C-8, although this reactivity has also not been mapped (Fig. 1E). Anti-Myc 9E10 recognizes amino acids
408-439 (Fig. 1G). When a population of HeLa
cells transfected with a Tax vector was costained with anti-Tax and
either C-33 or 9E10, clear images of c-Myc appeared in the nucleus,
regardless of whether the cell expressed Tax protein or not (Fig. 1, compare arrowed cells in D and E and those in F and G). These findings contrasted
with those obtained using the C-8 monoclonal antibody and suggested
that Tax expression did not perturb steady-state Myc levels, but
instead masked detection of one antigenic epitope. To better
understand this masking, we mapped the epitope recognized by the C-8
monoclonal antibody. Wild-type and 10 mutant proteins that contained
selected amino acid deletions were expressed in Escherichia coli (Fig. 2A). This panel of 11 Myc polypeptides was
probed with C-8 in immunoblot assays. The results revealed that
Myc 1-48 and Myc 106-143 were reactive to C-8,
while Myc 48-175 was not (Fig. 2A). Further
analysis revealed that an expressed peptide (silver staining of
proteins (Fig. 2B, left) and immunoblotting of
same proteins (Fig. 2B, right)) containing
only amino acids 45-130 was recognized by C-8 (Fig. 2B, lane 8), deductively narrowing the
epitope to amino acids 45-105. Of interest, we note that amino
acids 45-105 are wholly contained within the previously
characterized transcriptional activation domain of Myc (reviewed in (76) ).
Figure 2:
Mapping of the Myc epitope recognized by
the C-8 monoclonal antibody. A, a diagrammatic representation
of wild-type Myc and Myc deletions. The names for the constructs
incorporate the amino acid numbers demarcating the deletion boundaries.
All proteins were expressed in E. coli as fusion proteins and
resolved by SDS-polyacrylamide gel electrophoresis and then analyzed by
immunoblotting. Reactivity with the C-8 monoclonal antibody is
indicated as positive (+); absence of C-8 reactivity is indicated
as negative(-). B, silver staining (lanes
1-4) and Western blotting (lanes 5-8) of
selected polypeptides used in determining the C-8 epitope. Note that
Myc amino acids 45-130 (Myc45-130) (lanes 4 and 8) and Myc 1-48 (lanes 2 and 6)
are fully reactive with C-8, whereas the glutathione S-transferase (GST) control (lanes 1 and 5) and Myc 45-175 (lanes 3 and 7)
show no reactivity with C-8.
Tax Represses Myc-induced Anchorage-independent Cell
GrowthTax interference with the nuclear detection of the
N-terminal Myc activation domain suggested functional significance.
Possibly, some aspect of Myc function is perturbed in the presence of
Tax. Because singular overexpression of Myc confers
anchorage-independent growth to Rat1a cells(77) , we selected
for Rat1a cells that ectopically overexpress Myc and Tax and assessed
their growth phenotype. Starting with parental Rat1a cells (R1aH),
using hygromycin selection, cells that express Myc (RM8), Myc +
Tax (RM8X), or Myc + an inactive Tax mutant
(RM8XG320(19) ) were established (Fig. 3). Tax protein
in cells was verified by both immunofluorescence (Fig. 3A) and immunoblotting (Fig. 3B).
RM8X and RM8XG320 cells were found to express Tax, while R1aH and RM8
did not (Fig. 3, A and B). For Myc expression,
similar amounts (after normalizing for background protein intensities)
were detected for RM8 (Fig. 3D, lane 2), RM8X (lanes 3 and 4), and RM8XG320 (lanes 5 and 6). The lower level of endogenous Myc was not visualized
clearly in R1aH cells (Fig. 3D, lane 1) by
this assay. Overall, the immunoblots are consistent with the
complementary immunofluorescent images shown in Fig. 1,
confirming that Tax does not affect steady-state Myc levels.
Figure 3:
Tax represses Myc-induced
anchorage-independent cell growth. Three cell lines were established
from Rat1a (R1aH; Myc /Tax ) using
hygromycin coselection. The cell lines were characterized for
expression of Myc (RM8; Myc /Tax ),
Myc and wild-type Tax (RM8X;
Myc /Tax ), and Myc and mutant Tax
(RM8XG320; Myc /TaxG320 ) using
immunofluorescence and immunoblotting. A, images on the left
are stainings using anti-Tax serum, while the corresponding light-field
images are shown on the right. Expression of Tax was observed for RM8X
and RM8XG320. B, Western analyses of Tax expression. Tax (asterisks) was found in RM8X (lane 3) and RM8XG320 (lane 4). As a positive control, HeLa cells transfected with a
Tax-expressing plasmid are shown (lane 5). C, foci
formation in soft agar. Pictures show representative foci from equal
numbers of seeded R1aH, RM8, RM8X, and RM8XG320 cells. Note the large
colonies seen for RM8 and RM8XG320. These were absent for R1aH and
RM8X. D, Western analyses of Myc expression. RM8, RM8X, and
RM8XG320 expressed similar amounts of 64-kDa c-Myc after normalizing
for some intensity differences in background bands. RM8X and RM8XG320
samples were loaded in duplicates.
The
four established cell lines were assayed also for anchorage-independent
growth (Fig. 3C). When plated into soft agar, control
R1aH cells (Myc /Tax ) failed to form
significant colonies (Fig. 3C). RM8
(Myc /Tax ), consistent with previous
findings (77) , produced many large foci (Fig. 3C). RM8XG320 (Myc /inactive
Tax(19) ) resembled RM8 in also producing many large colonies.
However, RM8X (Myc /Tax ) (Fig. 3C), which expressed both Myc and Tax, showed
much reduced cell masses in agar. One interpretation of these results
is that Tax, perhaps as a consequence of epitope masking, repressed the
induction by Myc of anchorage independence in cells. We caution that
our findings do not eliminate the possibility that Tax has other more
general effects on the cells, thereby reducing proliferative capacity.
Tax Affects Transcriptional Activation by MycMyc
activates transcription from responsive promoters. A contribution of
the transcriptional activity of Myc to cellular transformation has been
suggested (reviewed in (76) ). That the N-terminal activation
domain of Myc (66, 71, 78, 79) is
perhaps conformationally altered in cells that express HTLV-I Tax
prompted us to examine what effect, if any, Tax has on Myc-modulated
transcription. To explore this issue, we introduced into CV-1 cells
chloramphenicol acetyltransferase reporter plasmids that contained
either tandem Myc-binding sites (MLPCAT) (Fig. 4, top)
or two point-mutated Myc-binding sites (MLPDMCAT) (Fig. 4, bottom), with a Myc expression vector (RSVmyc), and/or a Tax
expression vector (Tax), and/or a mutant Tax expression vector (TaxD).
Chloramphenicol acetyltransferase activities were determined 48 h
later. As expected, we observed that MLPCAT was activated significantly
by RSVmyc (Fig. 4, top). Interestingly, this
stimulation was abolished when Tax was coexpressed (Fig. 4, top). In contrast, cointroduction of a plasmid expressing an
inactive Tax mutant (TaxD) did not affect Myc activation of MLPCAT,
controlling for functional specificity. As additional controls, we
replicated the transfections using instead plasmid reporter MLPDMCAT (Fig. 4, bottom) that contained mutated Myc-responsive
elements. In this instance, promoter expression was not influenced by
coexpression of Myc, Tax, or Myc + Tax. These findings demonstrate
that intact Myc-binding sites are necessary for activation and that
functional Tax protein repressed this activation.
Figure 4:
Repression of Myc-dependent transcription.
MLPCAT (top) contains two copies of the Myc-binding motif
positioned in the adenovirus major late promoter chloramphenicol
acetyltransferase plasmid. MLPDMCAT (bottom) is MLPCAT with
the two point-mutated Myc motifs. Top, MLPCAT was
cotransfected with pUC19, with RSVmyc, with RSVmyc + pHTLVTax (RSVmyc+Tax; see (53) ), with RSVmyc +
pHTLVTax (RSVmyc+TaxD), and with pHTLVTax (Tax). Bottom, transfections were performed with
MLPDMCAT in place of MLPCAT; otherwise the transfections are identical
to those shown above. Tax is a Tax cDNA deleted in all amino acids
except for the N-terminal 58 residues. Data shown are averages from
experiments repeated twice.
Negative Signaling through a CREB/ATF Pathway Correlates
with Masking of MycTax activates gene expression
pleiotropically using at least two major signal transduction pathways
defined by either NF- B or CREB/ATF (reviewed in (8) and (10) ). Previously, we (19) and others (80) have delineated separate domains within Tax that specify
interaction with either NF- B or CREB/ATF. That analysis prompted
the generation of a series of single amino acid Tax mutants such that
different mutants were restricted to unimodal activation of either
CREB/ATF or NF- B. We tested six of these mutants (Fig. 5A) in Myc masking assays to characterize better
underlying mechanism(s). Tax mutants C23 (Fig. 5B, panels C and D), N43 (panels E and F), and A113 (panels G and H) have been
defined previously to activate only CREB/ATF. In contrast, TaxS29 (Fig. 5B, panels I and J), TaxN52 (panels K and L), and Tax284 (panels M and N) interact with NF- B, but not CREB/ATF(19) .
When these versions of Tax were introduced into cells followed by
simultaneous visualization for both Tax and Myc, we observed two types
of results. All three CREB/ATF-active Tax proteins masked Myc (Fig. 5B, panels C-H), while none of the
NF- B-active Tax polypeptides influenced Myc detection (panels
I-N). In other experiments, a direct protein-protein complex
between Tax and c-Myc was not found (not in glutathione S-transferase protein chromatography, coimmunoprecipitations,
or yeast two-hybrid assays; data not shown). Furthermore, the NF- B
and CREB/ATF mutations distributed to discrete regions in Tax (Fig. 5A), making it, although not impossible, unlikely
that any three-point mutations would define one domain for
protein-protein contact. Collectively, these findings favor a mechanism
linked to induction of CREB/ATF signaling rather than one of direct
stoichiometric protein-protein shielding for the masking phenomenon.
Figure 5:
CREB/ATF-active (but not NF- B-active)
forms of Tax mask Myc. A, shown is a linear diagrammatic
representation of the Tax protein. Tax mutants used for analyses are
indicated. Asterisks indicate the relative locations of the
mutations. The mutated amino acids are numbered below each asterisk.
Some of the previously identified structural and functional domains of
Tax are indicated. B, HeLa cells were seeded onto coverslips
and transfected with wild-type Tax (panels A and B)
or Tax mutant (panels C-N) plasmids followed by
immunostaining. Identical paired fields are shown on the left
(anti-Tax) and right (anti-Myc C-8). Arrows point to
Tax-expressing cells. Tax mutants TaxC23, TaxN43, and TaxA113 (panels C-H), active for CREB/ATF but inactive for
NF- B, masked Myc expression (see panels C and D, E and F, and G and H,
respectively). Mutants TaxS29, TaxN52, and Tax284 (panels
I-N), inactive for CREB/ATF but active for NF- B, did
not affect Myc detection (see panels I and J, K and L, and M and N,
respectively).
If Tax represses Myc detection through activation of cAMP-dependent
signaling, then one might expect that an independent means of cAMP
stimulation would produce a similar picture. To investigate this
possibility, we treated HeLa cells with the adenylate cyclase activator
forskolin and investigated whether activation of protein kinase A (PKA)
signaling, in the absence of Tax, perturbs the Myc C-8 epitope. We
observed that mock-treated cells stained well with either C-8 (Fig. 6A) or pan-reactive polyclonal (Fig. 6B) serum in double simultaneous stainings. In
contrast, cells incubated for 4 h with forskolin were not stained with
C-8 (Fig. 6C), while the polyclonal antiserum readily
visualized nuclear fluorescence of Myc in the identical cells (Fig. 6D).
Figure 6:
Effect of PKA modulation on masking of
Myc. HeLa cells were exposed to forskolin for 4 h, immediately fixed,
and stained. Myc masking was confirmed by comparing changes in the
intensity of C-8-specific fluorescence relative to fluorescence from
polyclonal pan-Myc. In untreated cells (A and B),
equal intensities were observed with the two antibodies. In the
presence of forskolin, C-8-specific immunostaining was reduced compared
with pan-Myc-specific immunostaining (compare C and D). In a converse assay, HeLa cells were seeded onto
coverslips and transfected with a Tax expression vector followed by
treatment with H-9 for 24 h. Tax expression was measured by
immunofluorescence in treated (G) and untreated (E)
cells. The same cells were simultaneously costained with the C-8
monoclonal antibody in treated (H) and untreated (F)
groups. Untreated HeLa cells showed reduced C-8 immunostaining in
Tax-expressing cells compared with Tax-negative cells (compare
intensities of Myc staining in Tax-expressing versus Tax-nonexpressing cells; F). Treatment of cells with H-9
blocked the ability of Tax to mask Myc (compare intensities of Myc
staining in Tax-expressing versus Tax-nonexpressing cells; H).
As a complementary assay, we reasoned
that if cAMP-PKA stimulation through either Tax or forskolin effects
masking, then inhibitors of PKA activation should blunt this effect. To
test this, we examined the ability of Tax to mask the C-8 epitope in
cells treated with kinase inhibitor H-9. HeLa cells seeded onto
coverslips were transfected with Tax-expressing plasmid and then
incubated with H-9 for 12 h. Cells were fixed and stained with
antiserum. In the absence of H-9, Tax-expressing cells (Fig. 6E) showed reduced C-8 fluorescence (Fig. 6F). Tax-expressing cells treated with with H-9 (Fig. 6G) recovered the normal intensity of C-8 as
compared with Tax-nonexpressing cells (Fig. 6H),
confirming that protein kinase inhibitors can blunt masking of Myc. We further studied cells that are genetically defective in the
cAMP-PKA axis. The murine B1R cell line is a PKA-defective clone
derived from the S49.1 lymphoma(81) . These cells fail to
respond to cAMP as the result of an absence of cAMP-binding
protein(82) . If cAMP-PKA signaling is required by Tax to mask
Myc, then one should observe staining of Myc by C-8 despite expression
of Tax in B1R cells. We, in fact, saw brightly stained Myc protein (Fig. 7E, arrowhead) in B1R cells that
expressed Tax (Fig. 7D, arrowhead). In
comparison, a suspension T-cell line (Jurkat) not defective in cAMP-PKA
signaling, when similarly stained with C-8 (Fig. 7B),
showed reduced Myc fluorescence in a cell that expressed Tax (Fig. 7A). Thus, the results from B1R (Fig. 7),
considered collectively with those from Tax mutants (Fig. 5) and
from forskolin- and protein kinase inhibitor-treated cells (Fig. 6), underscore a linkage between the cAMP-PKA signaling
pathway and Tax masking of the Myc C-8 epitope.
Figure 7:
Tax does not mask Myc in a cell line
defective for cAMP signaling. The ability of Tax to mask Myc was
measured in the PKA-defective cell line B1R and was compared with that
in Jurkat cells. Cells grown in suspension to 5 10 cells/ml were transfected with Tax-expressing plasmid. Following
transfection, the cells were washed in PBS and were settled onto
polylysine-derivatized coverslips. The adherent cells were fixed and
stained. Each pair of panels contains dual stainings of the identical
field of view. Jurkat cells were probed with anti-Tax and anti-Myc
(C-8) to determine Myc masking in T-cells (compare A and B). Tax-expressing cells (arrowheads) displayed
reduced C-8 fluorescence. B1R cells expressing transfected Tax were
similarly probed with anti-Tax and anti-Myc (C-8). In this case,
Tax-expressing cells (D) stained strongly with the C-8
monoclonal antibody (E). Light-field views of each group are
shown in C and F.
DISCUSSION
Tax functions are complex. Examples of activation of the
HTLV-I long terminal repeat through CREB/ATF and activation of the
promoters for human immunodeficiency virus type 1, interleukin-2R ,
and granulocyte-macrophage colony-stimulating factor (among others)
through NF- B illustrate intricate interplay between divergent
signaling pathways (reviewed in (8) and (10) ). In
understanding the role of Tax in HTLV-I lymphoproliferation, one faces
the issue of a long latency between virus infection and development of
ATL. Indeed, only a small minority of infected individuals (<5%)
progress to ATL, invariably more than 20-30 years after initial
exposure(9, 59, 60) . Hence, in
vivo, Tax is only mildly oncogenic, and its transforming
properties are arguably incidental to its pleiotropic effects on
cellular genes. Intuitively, it is reasonable that Tax cooperates
with cytoplasmic oncogenes such as ras(69) in
transformation. It was unexpected that Tax might antagonize the
anchorage-independent cell growth and transcription functions of Myc.
While the short half-lived Myc protein has been shown to be regulated
at discrete stages in transcriptional initiation, transcriptional
elongation, and post-transcriptional processing (reviewed in (62) ), regulation at the level of protein conformation has
not, heretofore, been proposed. The region in Myc perturbed by Tax
(amino acids 45-106) is contained within a highly conserved
transformation/activation
domain(66, 71, 78, 79, 83, 84, 85) .
While we do not understand fully the mechanistic details responsible
for the Tax-Myc interaction, our experimental evidence supports the
likelihood that the N-terminal portion of Myc is conformationally
altered by Tax, without additional effects on overall protein
stability. A conformational disruption of this protein domain could
reasonably account for an abrogation of Myc's transactivation and
transformation properties. p53 and Rb are two examples of regulatory
proteins targeted for modulation by viral oncogenes (reviewed in (86) ). While there are many biological instances in which
mechanisms such as phosphorylation and protein degradation are used to
control function, one of the increasingly common regulatory themes is
exemplified by formation of protein-protein complexes, such as those
between p53/Rb and viral oncoproteins. Indeed, in one setting, Myc
function is known to be regulated by direct binding to
Rb(84, 87) . In comparison, a common mechanism of Tax
action appears to be the facilitation of protein-protein dimerization.
This has been illustrated well by effects of Tax on bZIP proteins (38, 39, 40) that result in the stabilized
binding of these factors to cognate DNA
sites(36, 39) . However, Tax has also been shown to
contact directly CREB, bZIP, and other
proteins(33, 34, 35, 88, 89) ,
and this latter ability could, in part, explain its capacity to mold
conformationally receptive partners(36, 39) . A
direct protein-protein contact mechanism would be an attractive
explanation for the masking of Myc by Tax. While we cannot exclude this
possibility, we have, so far, been unable to recover evidence for a
Tax-Myc complex by physical/genetic means (i.e. coimmunoprecipitation, protein column chromatography, and yeast
two-hybrid assay; data not shown). On the other hand, our findings do
establish a strong correlation between the inhibition of Myc function
and Tax activity in CREB/ATF signaling. Since activation of CREB/ATF is
a requirement for Tax-mediated transformation(15) , our current
observations would support a proposition that embedded into activation
is a countervailing signal (transmitted as antagonism of Myc) that
moderates transformation. This duality of positive/negative effects
emanating from a single (CREB/ATF) pathway might be one
biosynthetically conservative strategy for maintaining cellular
homeostasis. Indeed, from other systems, it is not unexpected that
activation events in the cAMP-PKA axis also transduce repressive
signals (reviewed in (90) ). Viruses have complex symbioses
with cells. On the one hand, for optimal replication of viral genomes,
viruses activate cells to states of high synthetic capacity. On the
other hand, such activation with accompanied viral replication results
in cell death. Presumably, there is a fine balance in achieving a
``quasi-activated'' state. In terms of infected hosts, some
semblance of this is probably reflected in HTLV-I seropostive, but
asymptomatic, individuals(91) . Because uncontrolled activated
cellular expansion results in undesired ends for the virus (e.g. aggressive expansion of HTLV-I-infected cells leads to fulminant
ATL and rapid death of the
patient(9, 92, 93) , or recognition of
infected cells by host immune surveillance results in clearance of the
virus), it makes sense for viruses to evolve balanced control of
cellular metabolism. The long period (>20-30 years) of
asymptomatic latency and the low (<5%) disease
penetrance(59, 60) suggest that HTLV-I has very
successfully evolved a coexistence with host cells. In this regard, the
fact that some Tax effects activate host cell processes and other Tax
effects provide balanced repression would be consistent with this
evolution. Our observation of Tax-Myc masking serves an added example
of this balanced regulation. Similar findings (i.e. repression
of Myc activity by Tax) have been confirmed by others(89) ,
although with fewer molecular details. From a mechanistic
perspective, much remains to be addressed on the ability of Tax to mask
Myc. Because immunofluorescence analysis does not provide an
unambiguous interpretation, we are pursuing through genetic and
biochemical approaches the possibility that although Tax does not
directly contact Myc, some CREB/ATF-like bZIP proteins, modulated by
Tax, could serve surrogate roles. In this regard, we have recently
isolated by the yeast two-hybrid approach three novel cDNAs that encode
cellular proteins that bind Tax. ( )The biology of
Tax-cellular protein interactions is likely to be highly complex and
merits detailed investigation. We note, however, that recent findings
demonstrating that the adenovirus E1a gene product can at once
cooperate with a second oncogene to transform cells (94) and at
another serve as a tumor suppressor (95) suggest that some of
the non-intuitive observations with Tax are generally relevant and
similarly operative in other biological paradigms.
FOOTNOTES
- *
- This work was supported in part by the Intramural
AIDS Targeted Antiviral Program from the Office of the Director,
National Institutes of Health. The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore by hereby marked ``advertisement'' in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- §
- To whom correspondence should be addressed.
Tel.: 301-496-6680; Fax: 301-402-0226; kjeang{at}d4.niaid.pc.niaid.nih.gov.
- (
) - The abbreviations used are: HTLV-I, human T-cell
leukemia virus type I; ATL, adult T-cell leukemia; PBS,
phosphate-buffered saline; PKA, protein kinase A.
- (
) - O. J. Semmes and K.-T. Jeang, submitted for
publication.
- (
) - D. Y. Jin and K.-T. Jeang,
manuscript in preparation.
ACKNOWLEDGEMENTS
We thank W. Leonard, S. Smith, and J. Tal for critical
reading of the manuscript.
REFERENCES
- Poiesz, B. J.,
Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo,
R. C. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 7415-7419
[Abstract/Free Full Text]
- Yoshida, M., Miyoshi, I.,
and Hinuma, Y. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2031-2035
[Abstract/Free Full Text]
- Robert-Guroff, M., Nakao,
Y., Notake, K., Ito, Y., Sliski, A., and Gallo, R. C. (1982) Science 215, 975-978
[Abstract/Free Full Text]
- Sodroski, J. G., Rosen,
C. A., and Haseltine, W. A. (1984) Science 225, 381-385
[Abstract/Free Full Text]
- Cann, A. J., Rosenblatt,
J. D., Wachsman, W., Shah, N. P., and Chen, I. S. (1985) Nature 318, 571-574
[CrossRef][Medline]
[Order article via Infotrieve]
- Felber, B. K., Paskalis,
H., Kleinman-Ewing, C., Wong-Staal, F., and Pavlakis, G. N. (1985) Science 229, 675-679
[Abstract/Free Full Text]
- Fujisawa, J., Seiki, M.,
Kiyokawa, T., and Yoshida, M. (1985) Proc. Natl. Acad.
Sci. U. S. A. 82, 2277-2281
[Abstract/Free Full Text]
- Smith, M. R., and Greene,
W. C. (1991) J. Clin. Invest. 87, 761-766
- Feuer, G., and Chen, I.
S. (1992) Biochim. Biophys. Acta 1114, 223-233
[Medline]
[Order article via Infotrieve]
- Sodroski, J. (1992) Biochim. Biophys. Acta 1114, 19-29
[Medline]
[Order article via Infotrieve]
- Yoshida, M. (1993) Trends. Microbiol. 1, 131-135
[CrossRef][Medline]
[Order article via Infotrieve]
- Grassmann, R., Dengler,
C., Muller-Fleckenstein, I., Fleckenstein, B., McGuire, K., Dokhelar,
M. C., Sodroski, J. G., and Haseltine, W. A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 3351-3355
[Abstract/Free Full Text]
- Grassmann, R.,
Berchtold, S., Radant, I., Alt, M., Fleckenstein, B., Sodroski, J. G.,
Haseltine, W. A., and Ramstedt, U. (1992) J. Virol. 66, 4570-4575
[Abstract/Free Full Text]
- Tanaka, A., Takahashi,
C., Yamaoka, S., Nosaka, T., Maki, M., and Hatanaka, M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 1071-1075
[Abstract/Free Full Text]
- Smith, M. R., and
Greene, W. C. (1991) J. Clin. Invest. 88, 1038-1042
- Kelly, K., Davis, P.,
Mitsuya, H., Irving, S., Wright, J., Grassmann, R., Fleckenstein, B.,
Wano, Y., Greene, W., and Siebenlist, U. (1992) Oncogene 7, 1463-1470
[Medline]
[Order article via Infotrieve]
- Grossman, W. J., Kimata,
J. T., Wong, F. H., Zutter, M., Ley, T. J., and Ratner, L. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1057-1061
[Abstract/Free Full Text]
- Franklin, A. A., and
Nyborg, J. K. (1995) J. Biomed. Sci. 2, 17-29
[CrossRef][Medline]
[Order article via Infotrieve]
- Semmes, O. J., and Jeang, K.-T.
(1992) J. Virol. 66, 7183-7192, and references
[Abstract/Free Full Text]
cited therein
- Kim, S. J., Kehrl, J. H., Burton, J.,
Tendler, C. L., Jeang, K.-T., Danielpour, D., Thevenin, C., Kim, K. Y.,
Sporn, M. B., and Roberts, A. B. (1990) J. Exp. Med. 172, 121-129, and references cited therein
[Abstract/Free Full Text]
- Sakamoto, K. M., Nimer, S. D., Rosenblatt, J. D., and
Gasson, J. C. (1992) Oncogene 7, 2125-2130, and
[Medline]
[Order article via Infotrieve]
references cited therein
- Montminy, M. R.,
Sevarino, K. A., Wagner, J. A., Mandel, G., and Goodman, R. H. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 6682-6686
[Abstract/Free Full Text]
- Tsukada, T., Fink, J.
S., Mandel, G., and Goodman, R. H. (1987) J. Biol.
Chem. 262, 8743-8747
[Abstract/Free Full Text]
- Jeang, K.-T., Boros, I.,
Brady, J., Radonovich, M., and Khoury, G. (1988) J.
Virol. 62, 4499-4509
[Abstract/Free Full Text]
- Giam, C. Z., and Xu, Y.
L. (1989) J. Biol. Chem. 264, 15236-15241
[Abstract/Free Full Text]
- Tan, T. H., Jia, R., and
Roeder, R. G. (1989) J. Virol. 63, 3761-3768
[Abstract/Free Full Text]
- Kadison, P., Poteat, H.
T., Klein, K. M., and Faller, D. V. (1990) J. Virol. 64, 2141-2148
[Abstract/Free Full Text]
- Poteat, H. T., Chen, F.
Y., Kadison, P., Sodroski, J. G., and Haseltine, W. A. (1990) J. Virol. 64, 1264-1270
[Abstract/Free Full Text]
- Montminy, M. R., and
Bilezikjian, L. M. (1987) Nature 328, 175-178
[CrossRef][Medline]
[Order article via Infotrieve]
- Lin, Y. S., and Green,
M. R. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3396-3400
[Abstract/Free Full Text]
- Adam, E., Kerkhofs, P.,
Mammerickx, M., Kettmann, R., Burny, A., Droogmans, L., and Willems, L. (1994) J. Virol. 68, 5845-5853
[Abstract/Free Full Text]
- Willems, L., Kettmann,
R., Chen, G., Portetelle, D., Burny, A., and Derse, D. (1992) J. Virol. 66, 766-772
[Abstract/Free Full Text]
- Adya, N., and Giam, C.
Z. (1995) J. Virol. 69, 1834-1841
[Abstract]
- Yin, M. J., Paulssen, E.
J., Seeler, J. S., and Gaynor, R. B. (1995) J. Virol. 69, 3420-3432
[Abstract]
- Goren, I., Semmes, O.
J., Jeang, K.-T., and Moelling, K. (1995) J. Virol. 69, 5806-5811
[Abstract]
- Armstrong, A. P.,
Franklin, A. A., Uittenbogaard, M. N., Giebler, H. A., and Nyborg, J.
K. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7303-7307
[Abstract/Free Full Text]
- Franklin, A. A., Kubik,
M. F., Uittenbogaard, M. N., Brauweiler, A., Utaisincharoen, P.,
Matthews, M. A., Dynan, W. S., Hoeffler, J. P., and Nyborg, J. K. (1993) J. Biol. Chem. 268, 21225-21231
[Abstract/Free Full Text]
- Wagner, S., and Green,
M. R. (1993) Science 262, 395-399
[Abstract/Free Full Text]
- Baranger, A. M., Palmer,
C. R., Hamm, M. K., Giebler, H. A., Brauweiler, A., Nyborg, J. K., and
Schepartz, A. (1995) Nature 376, 606-608
[CrossRef][Medline]
[Order article via Infotrieve]
- Perini, G., Wagner, S.,
and Green, M. R. (1995) Nature 376, 602-605
[CrossRef][Medline]
[Order article via Infotrieve]
- Fujii, M.,
Sassone-Corsi, P., and Verma, I. M. (1988) Proc. Natl.
Acad. Sci. U. S. A. 85, 8526-8530
[Abstract/Free Full Text]
- Nagata, K., Ohtani, K.,
Nakamura, M., and Sugamura, K. (1989) J. Virol. 63, 3220-3226
[Abstract/Free Full Text]
- Alexandre, C., Charnay,
P., and Verrier, B. (1991) Oncogene 6, 1851-1857
[Medline]
[Order article via Infotrieve]
- Fujii, M., Tsuchiya, H.,
Chuhjo, T., Akizawa, T., and Seiki, M. (1992) Genes
& Dev. 6, 2066-2076
- Ballard, D. W.,
Bohnlein, E., Lowenthal, J. W., Wano, Y., Franza, B. R., and Greene, W.
C. (1988) Science 241, 1652-1655
[Abstract/Free Full Text]
- Bohnlein, E., Siekevitz,
M., Ballard, D. W., Lowenthal, J. W., Rimsky, L., Bogerd, H., Hoffman,
J., Wano, Y., Franza, B. R., and Greene, W. C. (1989) J. Virol. 63, 1578-1586
[Abstract/Free Full Text]
- Beraud, C., Sun, S. C.,
Ganchi, P., Ballard, D. W., and Greene, W. C. (1994) Mol. Cell. Biol. 14, 1374-1382
[Abstract/Free Full Text]
- Lacoste, J., Lanoix, J.,
Pepin, N., and Hiscott, J. (1994) Leukemia (Baltimore) 8, Suppl. 1,
S71-S76
- Munoz,
E., Courtois, G., Veschambre, P., Jalinot, P., and Israel, A. (1994) J. Virol. 68, 8035-8044
[Abstract/Free Full Text]
- Inoue, J., Seiki, M.,
Taniguchi, T., Tsuru, S., and Yoshida, M. (1986) EMBO
J. 5, 2883-2888
[Medline]
[Order article via Infotrieve]
- Cross, S. L., Feinberg,
M. B., Wolf, J. B., Holbrook, N. J., Wong-Staal, F., and Leonard, W. J. (1987) Cell 49, 47-56
[CrossRef][Medline]
[Order article via Infotrieve]
- Maruyama, M., Shibuya,
H., Harada, H., Hatakeyama, M., Seiki, M., Fujita, T., Inoue, J.,
Yoshida, M., and Taniguchi, T. (1987) Cell 48, 343-350
[CrossRef][Medline]
[Order article via Infotrieve]
- Ruben, S., Poteat, H.,
Tan, T. H., Kawakami, K., Roeder, R., Haseltine, W., and Rosen, C. A. (1988) Science 241, 89-92
[Abstract/Free Full Text]
- Siekevitz, M., Feinberg,
M. B., Holbrook, N., Wong-Staal, F., and Greene, W. C. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 5389-5393
[Abstract/Free Full Text]
- Lev, S., Moreno, H.,
Martinez, R., Canoll, P., Peles, E., Musacchio, J. M., Plowman, G. D.,
Rudy, B., and Schlessinger, J. (1995) Nature 376, 737-745
[CrossRef][Medline]
[Order article via Infotrieve]
- van Biesen, T., Hawes,
B. E., Luttrell, D. K., Krueger, K. M., Touhara, K., Porfiri, E.,
Sakaue, M., Luttrell, L. M., and Lefkowitz, R. J. (1995) Nature 376, 781-784
[CrossRef][Medline]
[Order article via Infotrieve]
- David, M., Petricoin,
E., Benjamin, C., Pine, R., Weber, M. J., and Larner, A. C. (1995) Science 269, 1721-1723
[Abstract/Free Full Text]
- Karin, M. (1990) New Biol. 2, 126-131
[Medline]
[Order article via Infotrieve]
- Hinuma, Y., Komoda, H.,
Chosa, T., Kondo, T., Kohakura, M., Takenaka, T., Kikuchi, M.,
Ichimaru, M., Yunoki, K., Sato, I., Matsuo, R., Takiuchi, Y., Uchino,
H., and Hanaoka, M. (1982) Int. J. Cancer 29, 631-635
[Medline]
[Order article via Infotrieve]
- Murphy, E. L., Hanchard,
B., Figueroa, J. P., Gibbs, W. N., Lofters, W. S., Campbell, M.,
Goedert, J. J., and Blattner, W. A. (1989) Int. J.
Cancer 43, 250-253
[Medline]
[Order article via Infotrieve]
- Majone, F., Semmes, O.
J., and Jeang, K.-T. (1993) Virology 193, 456-459
[CrossRef][Medline]
[Order article via Infotrieve]
- Marcu, K. B., Bossone,
S. A., and Patel, A. J. (1992) Annu. Rev. Biochem. 61, 809-860
[CrossRef][Medline]
[Order article via Infotrieve]
- Blackwell, T. K., Huang,
J., Ma, A., Kretzner, L., Alt, F. W., Eisenman, R. N., and Weintraub,
H. (1993) Mol. Cell. Biol. 13, 5216-5224
[Abstract/Free Full Text]
- Blackwood, E. M., and
Eisenman, R. N. (1991) Science 251, 1211-1217
[Abstract/Free Full Text]
- Amati, B., Dalton, S.,
Brooks, M. W., Littlewood, T. D., Evan, G. I., and Land, H. (1992) Nature 359, 423-426
[CrossRef][Medline]
[Order article via Infotrieve]
- Kato, G. J., Barrett,
J., Villa-Garcia, M., and Dang, C. V. (1990) Mol.
Cell. Biol. 10, 5914-5920
[Abstract/Free Full Text]
- Evan, G. I., Wyllie, A.
H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C.
M., Penn, L. Z., and Hancock, D. C. (1992) Cell 69, 119-128
[CrossRef][Medline]
[Order article via Infotrieve]
- Harrington, E. A.,
Bennett, M. R., Fanidi, A., and Evan, G. I. (1994) EMBO J. 13, 3286-3295
[Medline]
[Order article via Infotrieve]
- Pozzatti, R., Vogel, J.,
and Jay, G. (1990) Mol. Cell. Biol. 10, 413-417
[Abstract/Free Full Text]
- Semmes, O. J., and
Jeang, K.-T. (1995) J. Virol. 69, 1827-1833
[Abstract]
- Chou, E. Y., Dang, C.
V., and Hart, G. W. (1995) Proc. Natl. Acad. Sci. U.
S. A. 92, 4417-4421
[Abstract/Free Full Text]
- Graham, F. L., and Eb,
A. J. (1973) Virology 54, 536-539
[CrossRef][Medline]
[Order article via Infotrieve]
- Gorman, C. M., Moffat,
L. F., and Howard, B. H. (1982) Mol. Cell. Biol. 2, 1044-1051
[Abstract/Free Full Text]
- Laemmli, U. K. (1970) Nature 227, 680-685
[CrossRef][Medline]
[Order article via Infotrieve]
- Johnson, D. A., Gautsch,
J. W., Sportsman, J. R., and Elder, J. H. (1995) Gene
Anal. Tech. 1, 3-8
- Dang, C. V. (1991) Biochim. Biophys. Acta 1072, 103-113
[Medline]
[Order article via Infotrieve]
- Small, M. B., Hay, N.,
Schwab, M., and Bishop, J. M. (1987) Mol. Cell. Biol. 7, 1638-1645
[Abstract/Free Full Text]
- Gu, W., Bhatia, K.,
Magrath, I. T., Dang, C. V., and Dalla-Favera, R. (1994) Science 264, 251-254
[Abstract/Free Full Text]
- Albert, T., Urlbauer,
B., Kohlhuber, F., Hammersen, B., and Eick, D. (1994) Oncogene 9, 759-763
[Medline]
[Order article via Infotrieve]
- Smith, M. R., and
Greene, W. C. (1990) Genes & Dev. 4, 1875-1885
- Coffino, P., Bourne, H.
R., and Tomkins, G. M. (1974) J. Cell. Physiol. 85, 603-610
- Bourne, H. R., Coffino,
P., and Tomkins, G. M. (1975) J. Cell. Physiol. 85, 611-620
[CrossRef][Medline]
[Order article via Infotrieve]
- Stone, J., de Lange, T.,
Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., and Lee, W. (1987) Mol. Cell. Biol. 7, 1697-1709
[Abstract/Free Full Text]
- Rustgi, A. K., Dyson,
N., and Bernards, R. (1991) Nature 352, 541-544
[CrossRef][Medline]
[Order article via Infotrieve]
- Pulverer, B. J., Fisher,
C., Vousden, K., Littlewood, T., Evan, G., and Woodgett, J. R. (1994) Oncogene 9, 59-70
[Medline]
[Order article via Infotrieve]
- Haffner, R., and Oren,
M. (1995) Curr. Opin. Genet. & Dev. 5, 84-90
- Beijersbergen, R. L.,
Hijmans, E. M., Zhu, L., and Bernards, R. (1994) EMBO
J. 13, 4080-4086
[Medline]
[Order article via Infotrieve]
- Caron, C., Rousset, R.,
Beraud, C., Moncollin, V., Egly, J. M., and Jalinot, P. (1993) EMBO J. 12, 4269-4278
[Medline]
[Order article via Infotrieve]
- Uittenbogaard, M. N.,
Armstrong, A. P., Chiaramello, A., and Nyborg, J. K. (1994) J. Biol. Chem. 269, 22466-22469
[Abstract/Free Full Text]
- Perrimon, N. (1995) Cell 80, 517-520
[CrossRef][Medline]
[Order article via Infotrieve]
- Osame, M., and Ijichi,
S. (1993) Med. Hypotheses 41, 363-366
[CrossRef][Medline]
[Order article via Infotrieve]
- Essex, M. (1992) AIDS Res. Hum. Retroviruses 8, 719-724
[Medline]
[Order article via Infotrieve]
- Sherman, M. P., Dube, D.
K., Saksena, N. K., and Poiesz, B. J. (1993) Cancer
Treat. Res. 64, 79-103
[Medline]
[Order article via Infotrieve]
- Ruley, H. (1983) Nature 204, 602-606
[CrossRef]
- Frisch, S. M. (1994) J. Cell Biol. 127, 1085-1096
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. A. Fryrear, S. S. Durkin, S. K. Gupta, J. B. Tiedebohl, and O. J. Semmes
Dimerization and a Novel Tax Speckled Structure Localization Signal Are Required for Tax Nuclear Localization
J. Virol.,
June 1, 2009;
83(11):
5339 - 5352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Awasthi, A. Sharma, K. Wong, J. Zhang, E. F. Matlock, L. Rogers, P. Motloch, S. Takemoto, H. Taguchi, M. D. Cole, et al.
A Human T-Cell Lymphotropic Virus Type 1 Enhancer of Myc Transforming Potential Stabilizes Myc-TIP60 Transcriptional Interactions
Mol. Cell. Biol.,
July 15, 2005;
25(14):
6178 - 6198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Forgacs, S. K. Gupta, J. A. Kerry, and O. J. Semmes
The bZIP Transcription Factor ATFx Binds Human T-Cell Leukemia Virus Type 1 (HTLV-1) Tax and Represses HTLV-1 Long Terminal Repeat-Mediated Transcription
J. Virol.,
June 1, 2005;
79(11):
6932 - 6939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Choe and K. Kirkegaard
Intracellular Topology and Epitope Shielding of Poliovirus 3A Protein
J. Virol.,
June 1, 2004;
78(11):
5973 - 5982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Calomme, T. L.-A. Nguyen, Y. de Launoit, V. Kiermer, L. Droogmans, A. Burny, and C. Van Lint
Upstream Stimulatory Factors Binding to an E Box Motif in the R Region of the Bovine Leukemia Virus Long Terminal Repeat Stimulates Viral Gene Expression
J. Biol. Chem.,
March 8, 2002;
277(11):
8775 - 8789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Kibler and K.-T. Jeang
CREB/ATF-Dependent Repression of Cyclin A by Human T-Cell Leukemia Virus Type 1 Tax Protein
J. Virol.,
March 1, 2001;
75(5):
2161 - 2173.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Riou, F. Bex, and L. Gazzolo
The Human T Cell Leukemia/Lymphotropic Virus Type 1 Tax Protein Represses MyoD-dependent Transcription by Inhibiting MyoD-binding to the KIX Domain of p300. A POTENTIAL MECHANISM FOR Tax-MEDIATED REPRESSION OF THE TRANSCRIPTIONAL ACTIVITY OF BASIC HELIX-LOOP-HELIX FACTORS
J. Biol. Chem.,
March 31, 2000;
275(14):
10551 - 10560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Burton, C. D. Upadhyaya, B. Maier, T. J. Hope, and O. J. Semmes
Human T-Cell Leukemia Virus Type 1 Tax Shuttles between Functionally Discrete Subcellular Targets
J. Virol.,
March 1, 2000;
74(5):
2351 - 2364.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Thebault, F. Gachon, I. Lemasson, C. Devaux, and J.-M. Mesnard
Molecular Cloning of a Novel Human I-mfa Domain-containing Protein That Differently Regulates Human T-cell Leukemia Virus Type I and HIV-1 Expression
J. Biol. Chem.,
February 18, 2000;
275(7):
4848 - 4857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Neuveut, K. G. Low, F. Maldarelli, I. Schmitt, F. Majone, R. Grassmann, and K.-T. Jeang
Human T-Cell Leukemia Virus Type 1 Tax and Cell Cycle Progression: Role of Cyclin D-cdk and p110Rb
Mol. Cell. Biol.,
June 1, 1998;
18(6):
3620 - 3632.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. G. Butscher, C. M. Haggerty, S. Chaudhry, and K. Gardner
Targeting of p300 to the Interleukin-2 Promoter via CREB-Rel Cross-talk during Mitogen and Oncogenic Molecular Signaling in Activated T-cells
J. Biol. Chem.,
July 13, 2001;
276(29):
27647 - 27656.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|